Agilus Launches Advanced Obesity Test Suite for Metabolic Care

India’s rising weight burden is pushing healthcare forward, and Agilus Diagnostics is stepping in with a bold move.

The company has rolled out its new obesity test suite, built to give clinicians deeper insight into insulin resistance, metabolic stress, and long-term health risks.

The launch comes as GLP-1–based therapies surge in popularity. With obesity rates climbing—nearly one in four women and two in five men now overweight—industry leaders say the moment calls for stronger diagnostic support. Urban prevalence has already touched 30–40%, driven by fast-changing lifestyles.

Also Read: Personalized Hygiene Care Tailoring Products to Individual Needs

Agilus’ Vital Shape lineup brings structured, layered testing to a space that has long needed standardization. The Vital Shape Lite panel includes 72 parameters, covering BMI, CMP, eGFR, CBC, lipid and thyroid profiles, HbA1c, fasting insulin, HOMA-IR, FIB-4, iron studies, and vitamin D and B12 levels. The Vital Shape Core panel adds hsCRP and extra nutritional and metabolic markers. The top-tier Vital Shape Ultra expands to 86 parameters, including leptin, adiponectin, amylase, lipase, and PTH with calcium—giving clinicians a clearer picture of fatty liver, inflammation, and hormonal imbalance.

Dr Anand K, Managing Director & CEO, Agilus Diagnostics, said: “We are witnessing a global shift in obesity care, especially with the increasing use of GLP-1–based therapies. As clinical practices evolve, diagnostics must evolve with them. Complete Care Vital Shape empowers clinicians with comprehensive insights into insulin resistance, fatty liver, metabolic syndrome and cardiometabolic disorders.

Dr Ajay Phadke, Director – Strategic Business Development, Agilus Diagnostics, added: “Over the last quarter, we have seen a sharp rise in enquiries for structured assessments around obesity management, high-insulin states and metabolic dysfunction.